Medifirst Solutions, Inc (OTCPK:MFST) announced that it has entered into a securities purchase agreement for a private placement of a 8% convertible redeemable promissory note for gross proceeds of $53,500 with GS Capital Partners LLC on February 20, 2019. The note carries a fixed interest at the rate of 8% and would mature on August 20, 2020. The note is issued at discount of $500 to principal of $54,000. The company has the right to prepay the note equal to 110% of the principal amount due plus any accrued but unpaid interest up to 90 days of issue and 125% beyond 90 days of issue. The note is convertible into common stock at a conversion price equal to 55% of lowest closing bid prices of common stock during the 15 trading days period prior to conversion. The company has paid $3,500 as legal fees to investor and received net proceeds of $50,000. The securities are issued pursuant to exemption provided under Section 4(a)(2) of the Securities Act of 1933.